Time to act on trials
Many of the worst economic and bureaucratic burdens that have proved such a deterrent to multi-country clinical trials look set to be addressed with the overhaul of the EU Clinical Trials Directive, but should we [more]
Many of the worst economic and bureaucratic burdens that have proved such a deterrent to multi-country clinical trials look set to be addressed with the overhaul of the EU Clinical Trials Directive, but should we [more]
Though well-intended, the European Clinical Trials Directive severely impeded clinical research. The Commission is now trying to revise the Directive, and is inviting researchers, patient groups and others to submit concrete suggestions. Download full article
The European Union aims to become the most competitive and dynamic knowledge-based economy in the world. Why then does it put so many obstacles in the way of research? And why is a world-beating breast [more]